Pharmacophore Development and SAR Studies of Imidazoline Receptor Ligands

E-ISSN： 1875-5607|12|14|1542-1555

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.12, Iss.14, 2012-12, pp. : 1542-1555

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Imidazoline receptor ligands:cardiovascular applications

By Bousquet P. Feldman J. Monassier L.

Expert Opinion on Emerging Drugs, Vol. 3, Iss. 1, 1998-06 ,pp. : 113-120

Informa Healthcare

Access to resources Recommend Favorite

Pharmacophore Models for Metabotropic 5-HT Receptor Ligands

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 18, 2006-09 ,pp. : 2005-2026

Bentham Science Publishers

Access to resources Recommend Favorite

Application of Ligand SAR, Receptor Modeling and Receptor Mutagenesis to the Discovery and Development of a New class of 5-HT2A Ligands

Current Topics in Medicinal Chemistry, Vol. 2, Iss. 6, 2002-06 ,pp. : 575-598

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacology of CCKRs and SAR Studies of Peptidic Analog Ligands

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 12, 2007-06 ,pp. : 1173-1179

Bentham Science Publishers

Access to resources Recommend Favorite

Receptor ligands and imidazoline secretagogues mediate their insulin secretory effects by activating distinct receptor systems in isolated islets

By Chan S.L.F. Morgan N.G.

European Journal of Pharmacology, Vol. 350, Iss. 2, 1998-06 ,pp. : 267-272

Elsevier

Access to resources Recommend Favorite